Title
Category
Credits
Event date
Cost
  • Behavioral health
  • Older adults
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activity will provide an overview of the negative impacts of ageism and ableism on health, longevity, happiness, and the personal and professional aspects of individuals’ lives. It will also discuss the intersectionality of aging and ability status, and the varying effects these types of discrimination may have on individuals.
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
The successful management of obesity—a complex, chronic and relapsing disease—through sustainable weight loss interventions can greatly improve individuals’ overall health status and diminish the severity of concomitant diseases such as diabetes. This activity will provide an overview of obesity and diabetes that describes effective multi-interventional approaches to weight loss and, importantly, highlights the role of incorporated lifestyle changes in promoting the likelihood of weight loss success and improved health outcomes. The conversational style of this activity will encourage discussion around obesity-care planning and examine the factors that must be considered due to the chronic and relapsing characteristics of this disease.
  • Transplantation
  • 5.50 ACPE - Pharmacists
  • 5.50 ACPE - Pharmacy Technicians
  • 5.50 AMA - Physicians
  • 5.50 ANCC - Nurses
  • 5.50 APA - Psychologists
  • 5.50 Attendance - General Attendance
  • 5.50 CCMC - General - Case Managers
  • 5.50 CDR - Dietitians
  • 5.50 ASWB - Social Workers
$0.00
Throughout these activities, faculty will discuss the keys to optimize the management/benefits of individuals undergoing organ or blood/marrow transplant. Participants will learn about advances, trends and updates on relevant topics within this field.
  • Transplantation
  • 6.00 ACPE - Pharmacists
  • 6.00 ACPE - Pharmacy Technicians
  • 6.00 AMA - Physicians
  • 6.00 ANCC - Nurses
  • 6.00 APA - Psychologists
  • 6.00 Attendance - General Attendance
  • 6.00 CCMC - General - Case Managers
  • 6.00 CDR - Dietitians
  • 6.00 ASWB - Social Workers
$0.00
Throughout these activities, faculty will discuss the keys to optimize the management/benefits of individuals with cancer. Participants will hear about current topics and exciting advances in the field of oncology.
  • Transplantation
  • 5.50 ACPE - Pharmacists
  • 5.50 ACPE - Pharmacy Technicians
  • 5.50 AMA - Physicians
  • 5.50 ANCC - Nurses
  • 5.50 APA - Psychologists
  • 5.50 Attendance - General Attendance
  • 5.50 CDR - Dietitians
  • 5.50 ASWB - Social Workers
$0.00
The Medical Director and Clinician Leadership Forum is designed to bring medical directors and other executive clinical leaders together to learn from nationally recognized practitioners and thought leaders. Faculty will share their insights into topics that are critical to the management of large patient populations.
  • Oncology
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Bladder cancer (BC) is the tenth most common cancer worldwide, and its associated five-year survival rate declines rapidly (from 96% to 6%) as it progresses from in situ through local invasion, regional spread and finally to distal spread. Thus, early detection and timely therapeutic interventions are crucial to improve outcomes and reduce the burden of disease. Outcomes have been further improved by the integration of recently approved therapies for BC, the utilization of biomarkers to guide treatment plans and the opportunity for eligible patients with BC to enroll in clinical trials. For all treatment plans, effective communication among the health care team is crucial for providing comprehensive care for this condition. This activity will provide participants with an overview of early BC diagnosis and its impact on survival rates. It will explore recently approved therapies for BC both as standalone treatments and in combination with established therapeutic approaches. Emerging therapies and their potential benefits will be examined, and the value of biomarkers will be discussed. Participants will gain insight into treatment strategies to optimize patient outcomes in BC.
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Caring for patients with complex medical conditions can be emotionally challenging for health care providers, particularly when difficult conversations need to be had with patients and their loved ones. This session will explore complex grief, its symptoms, and how health care professionals can recognize it in themselves and their patients, as well as provide strategies for managing grief and supporting patients and families.
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
While scientists are still working to identify and clarify all of the functions of sleep, decades of studies have confirmed that sleep is of fundamental importance for various physical and cognitive processes and even survival. Studies have also identified potentially catastrophic effects of lack of sleep on health, wellness, and brain function. This presentation will discuss research that indicates the impact of sleep deprivation on the body and examine the role of underdiagnosed sleep apnea as a significant threat to public health.
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Patient-reported outcomes (PRO) are crucial in evaluating the impact of health care professionals, teams, and systems on patients’ health, quality of life, and treatment outcomes. By consistently tracking PRO scores, health care organizations can pinpoint areas of excellence and opportunities for improvement, as well as compare the effectiveness of different treatment options. This presentation will explore the benefits of PRO measures in health care and provide insights on how to seamlessly integrate these measures into clinical practice. Strategies for interpreting and utilizing PRO data to improve health care quality will also be highlighted.
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Pediatric patients referred for heart transplant (HTx) due to congenital heart disease (CHD) are considered high-risk due to their disease complexity and their specific peritransplant surgical risks. However, there has been great improvement in pediatric CHD outcomes treated with HTx- and surgical therapies, especially with the use of ventricular assist devices (VADs). This session will review the current state of HTx for pediatric CHD, addressing issues such as mortality risk factors, waitlist mortality, mechanical-support options, and immunosuppression and antibody-mediated rejection. It will also discuss key issues for this population, including psychosocial challenges, rehabilitation goals and future expectations regarding functional outcomes.

Pages